PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
Using existing data from A5274 and data obtained from retrospectively testing available biospecimens, we propose the following...
